Best practice guidelines for melanoma care go digital
28 October 2016
Health professionals treating melanoma patients have access to the first in a series of new, wiki-based clinical recommendations with the launch of electronic clinical practice guidelines for the diagnosis and management of melanoma.
The release of the renewed resource, in Sydney at the Australasian Melanoma Conference, marks the first time a melanoma management guideline has been published in a wiki format for continual electronic update.
The first in a comprehensive series of updated melanoma guidelines, it provides evidence-based recommendations on the recognition of melanomas, biopsy of suspicious lesions, when to perform sentinel node biopsy and margins for radical excision of primary melanomas.
The guidelines are being developed in partnership by Cancer Council Australia and Melanoma Institute Australia, with additional funding from the Skin Cancer College Australasia.
Chair of the project’s expert working group, Professor John Thompson AO, said the guidelines were the result of an exhaustive systematic review and public consultation process and were being launched at a time of rapid change in the management of melanoma.
“Things are moving quickly in melanoma management,” Professor Thompson said. “A comprehensive systematic review of the evidence was timely.
“The publication of updated guidelines on Cancer Council Australia’s wiki platform means they can now be continually reviewed as new evidence becomes available. Using wiki software also means that we can publish guidelines in sections as they are finalised, rather than waiting for large paperbased volumes to be printed and distributed.”
One of the most significant changes in recommended practice in the new guideline was a strengthening of the evidence for sentinel node biopsy.
“The review found new evidence to support the use of sentinel node biopsy to accurately stage melanoma,” Professor Thompson said. “This is particularly important, given the advent of new effective but high-cost drugs that may be of value in appropriately staged patients.”
The guidelines will cover prevention, diagnosis, management and follow-up as well as special population groups such as children and pregnant women. The full set of guidelines is expected to be completed and published by early 2018.
The new set of guidelines are available online.
Read more on our Research Blog.
Sydney Health Partners' goal is to ensure world class research is successfully implemented & scaled-up to benefit patients & wider society.
Promising young MIA researcher conferred with University of Sydney PhD.
Jana Pittman and Melinda Gainsford-Taylor urge Australians to be sun-safe and check their skin as they join the Game On Mole campaign in support of their much-loved coach
Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.
Honouring the exceptional impact of his work on communities around the world.
MIA's Co-Medical Directors receive University of Sydney's Vice-Chancellor's Award for Outstanding Research
Awarded for their life-saving discoveries transforming melanoma patient care.
National day of action called amidst fears COVID lockdowns have deterred patients from seeking potentially life-saving medical treatment
Recognising her pioneering work in immunotherapy in melanoma, transforming the care of patients worldwide.
Clinicians and researchers from across Australia and beyond united online, bringing the AMC2021 conference theme of Promising Futures to life.
Melanoma Institute Australia is proud to announce that the Nine Network’s Peter Overton AM has joined us as a National Ambassador.
MIA is proud to announce that five of our researchers have been named on the Clarivate Annual Highly Cited Researchers™ 2021 list.
New research shows routine skin checks by a health professional, coupled with checking your own skin, are vital in saving lives from melanoma.
With new patient figures indicating people may have deferred skin checks during the pandemic our Game On Mole campaign is more important than ever.
We are excited to announce a return to our much-loved physical Melanoma March events in March 2022!
Read more about the wonderful MIA community fundraising initiatives held recently.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
Over two fun, yet challenging, days in September an intrepid group of riders and crew successfully completed the annual Melanoma Bike Bash in WA!
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
Three MIA researchers at University of Sydney received grants to further their important melanoma research.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.